B cells generated by B-1 development can progress to chronic lymphocytic leukemia

Annals of the New York Academy of Sciences

Volumn 1362, Issue 1, 2015, Pages 250-255

  Hayakawa, Kyoko ^a   Formica, Anthony M ^a   Colombo, Matthew J ^a   Ichikawa, Daiju ^a,b   Shinton, Susan A ^a   Brill Dashoff, Joni ^a   Hardy, Richard R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Autoreactive BCR; B cell subsets; B 1 development; B CLL; B1a

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B 1 CELL; B LYMPHOCYTE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENETIC MODEL; GERM LINE; INTRACELLULAR SIGNALING; LEUKEMOGENESIS; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; RECEPTOR GENE; TRANSGENIC MOUSE; ANIMAL; DISEASE COURSE; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; DISEASE PROGRESSION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICE; RECEPTORS, ANTIGEN, B-CELL;

EID: 84959471103     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12768     Document Type: Article

References (38)

1. + B cells: the Ly-1 B lineage? Annu. Rev. Immunol. 6: 197-218.
2. Morton, L.M. et al. 2006. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107: 265-276.
3. Royston, I. et al. 1980. Human T cell antigens defined by monoclonal antibodies: the 65000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J. Immunol. 125: 725-731.
4. Wang, C.Y. et al. 1980. Identification of a p69, 71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J. Exp. Med. 151: 1539-1544.
5. Hayakawa, K. et al. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
6. Herzenberg, L.A. & A.B. Kantor. 1993. B-cell lineages exist in the mouse. Immunol. Today 14: 79-83.
7. Hayakawa, K., R.R. Hardy & L.A. Herzenberg. 1985. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161: 1554-1568.
8. Hayakawa, K. et al. 1986. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16: 1313-1316.
9. Hardy, R.R. et al. 1987. Rheumatoid factor secretion from human Leu-1+ B cells. Science 236: 81-83.
10. Bichi, R. et al. 2002. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl. Acad. Sci. U.S.A. 99: 6955-6960.
11. Hayakawa, K. et al. Early generated B1 B cells in mice become chronic lymphocytic leukemia. Submitted.
12. Hardy, R.R. & K. Hayakawa. 1991. A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. U.S.A. 88: 11550-11554.
13. Yuan, J. et al. 2012. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335: 1195-1200.
14. Zhou, Y. et al. 2015. Lin28b promotes fetal B lymphopoiesis through the transcription factor Arid3a. J. Exp. Med. 212: 569-580.
15. Hayakawa, K. & R.R. Hardy. 2000. Development and function of B-1 cells. Curr. Opin. Immunol. 12: 346-353.
16. Azzam, H. S. et al. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311.
17. Wortis, H. H. et al. 1995. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc. Natl. Acad. Sci. U.S.A. 92: 3348-3352.
18. Hayakawa, K. et al. 1999. Positive selection of natural autoreactive B cells. Science 285: 113-116.
19. Hayakawa, K. et al. 2003. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197: 87-99.
20. Ichikawa, D. et al. 2015. Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells. J. Immunol. 194: 606-614.
21. Hayakawa, K. et al. 1990. Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J. Exp. Med. 172: 869-878.
22. Eisenberg, R.A. et al. 1979. Natural thymocytotoxic autoantibodies in autoimmune and normal mice. J. Immunol. 122: 2272-2278.
23. + T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope. J. Immunol. 163: 4796-4804.
24. Wen, L. et al. 2005. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 23: 297-308.
25. Rickert, R.C., K. Rajewsky & J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352-355.
26. Martin, F. & J.F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12: 39-49.
27. Engel, P. et al. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3: 39-50.
28. Otero, D.C., A.N. Anzelon & R.C. Rickert. 2003. CD19 function in early and late B cell development. I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J. Immunol. 170: 73-83.
29. Depoil, D. et al. 2008. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 9: 63-72.
30. Foote, J. 2003. Immunology: isomeric antibodies. Science 299: 1327-1328.
31. James, L.C., P. Roversi & D.S. Tawfik. 2003. Antibody multispecificity mediated by conformational diversity. Science 299: 1362-1367.
32. Wedemayer, G.J. et al. 1997. Structural insights into the evolution of an antibody combining site. Science 276: 1665-1669.
33. + B cells. Immunol. Rev. 197: 60-74.
34. Chu, C.C. et al. 2008. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood 112: 5122-5129.
35. Chu, C.C. et al. 2010. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 115: 3907-3915.
36. Ehrenstein, M.R. & C.A. Notley. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
37. Wen, L. et al. 2005. Association of B-1 B cells with follicular dendritic cells in spleen. J. Immunol. 174: 6918-6926.
38. Herishanu, Y. et al. 2011. The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117: 563-574.